ConductScience.org, home

Paper7628985

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

van Etten EW and 4 others. J Antimicrob Chemother, 1995. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. Papers, record 7628985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7628985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
2.93
iCite
Revised in PubMed
2019-05-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Etten EWE W
2Otte-Lambillion MM
3van Vianen WW
4ten Kate MTM T
5Bakker-Woudenberg AJA J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amphotericin BMajor topic
CandidiasisMajor topic
LeukopeniaMajor topic
Animals
Chromatography, High Pressure Liquid
Cyclophosphamide
Drug Carriers
Female
Gallium Radioisotopes
Isotope Labeling
Liposomes
Mice
Mice, Inbred BALB C
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
36411251Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.J Antimicrob Chemother2022https://conductscience.org/library/papers/36411251PubMed
35970966Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity.AAPS PharmSciTech2022https://conductscience.org/library/papers/35970966PubMed
34634395Nanomedicine to fight infectious disease.Adv Drug Deliv Rev2021https://conductscience.org/library/papers/34634395PubMed
34633846DectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/34633846PubMed
33523419Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections.Infect Dis Ther2021https://conductscience.org/library/papers/33523419PubMed
31222254Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.Clin Infect Dis2019https://conductscience.org/library/papers/31222254PubMed
30962332In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30962332PubMed
29263075Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29263075PubMed
28928478Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Sci Rep2017https://conductscience.org/library/papers/28928478PubMed
28630200Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28630200PubMed
23793994Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.Pharm Res2014https://conductscience.org/library/papers/23793994PubMed
22131622Formulation and Evaluation of Long Circulating Liposomal Amphotericin B: A Scinti-kinetic Study using Tc in BALB/C Mice.Indian J Pharm Sci2011https://conductscience.org/library/papers/22131622PubMed
21151883A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model.PLoS Negl Trop Dis2010https://conductscience.org/library/papers/21151883PubMed
17722276Optimizing efficacy of amphotericin B through nanomodification.Int J Nanomedicine2006https://conductscience.org/library/papers/17722276PubMed
16641459Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16641459PubMed
16436726Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16436726PubMed
16304147
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16304147PubMed
12019089Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12019089PubMed
11709329Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11709329PubMed
10681316A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10681316PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7628985

GET https://conductscience.org/api/papers/v1/7628985/cited_by?page=2